Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5185652
Max Phase: Preclinical
Molecular Formula: C32H50ClNO9
Molecular Weight: 628.20
Associated Items:
ID: ALA5185652
Max Phase: Preclinical
Molecular Formula: C32H50ClNO9
Molecular Weight: 628.20
Associated Items:
Canonical SMILES: CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CC(=O)OC(C)(C)C)C[C@@](O)(CCl)[C@@H]2O)O[C@@H]1C
Standard InChI: InChI=1S/C32H50ClNO9/c1-19(10-13-27-30(38)32(39,18-33)17-24(42-27)16-29(37)43-31(6,7)8)9-12-26-20(2)15-25(22(4)41-26)34-28(36)14-11-21(3)40-23(5)35/h9-11,13-14,20-22,24-27,30,38-39H,12,15-18H2,1-8H3,(H,34,36)/b13-10+,14-11-,19-9+/t20-,21-,22+,24+,25+,26-,27+,30+,32+/m0/s1
Standard InChI Key: UNQZBKKAIFNDAM-MRBWBORZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 628.20 | Molecular Weight (Monoisotopic): 627.3174 | AlogP: 3.91 | #Rotatable Bonds: 11 |
Polar Surface Area: 140.62 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.64 | CX Basic pKa: | CX LogP: 2.96 | CX LogD: 2.96 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.13 | Np Likeness Score: 2.16 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):